Asker Healthcare Group AB (FRA:I88) Other Financing: €-1 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:I88 Asker Healthcare Group AB FRA:I88
23 GF Score
Price €7.29
! 3 Warning Signs
View Full Analysis

What is Asker Healthcare Group AB Other Financing?

Asker Healthcare Group AB FRA:I88 +1.75% 23 Other Financing is €-1 Mil as of Mar. 2026. GuruFocus rates FRA:I88 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review.

Asker Healthcare Group AB's Other Financing for the three months ended in Mar. 2026 was €0 Mil.

Asker Healthcare Group AB's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was €-1 Mil.

Asker Healthcare Group AB Other Financing Historical Data

* Premium members only.

The historical data trend for Asker Healthcare Group AB's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asker Healthcare Group AB Other Financing Chart

Asker Healthcare Group AB Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Financing
0.45 -0.36 0.70 0.83

Asker Healthcare Group AB Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 2.10 -0.09 -1.27 0.00 0.00
FRA:I88
23GF Score
Asker Healthcare Group AB FRA:I88
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asker Healthcare Group AB Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €-1 Mil mean?
Asker Healthcare Group AB (FRA:I88) has a Other Financing of €-1 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Asker Healthcare Group AB and its competitors.
Is Asker Healthcare Group AB's Other Financing too high?
Asker Healthcare Group AB's current Other Financing is €-1 Mil. Overall, Asker Healthcare Group AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's Other Financing compare to MCK and CAH?
Asker Healthcare Group AB's Other Financing of €-1 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Distribution company?
A good Other Financing depends on the Medical Distribution industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Asker Healthcare Group AB and its competitors. Asker Healthcare Group AB's current Other Financing is €-1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (FRA:I88) has a current Other Financing of €-1 Mil. The current Other Financing is €-1 Mil. Asker Healthcare Group AB's overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Asker Healthcare Group AB (FRA:I88), the current Other Financing is €-1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asker Healthcare Group AB Business Description

Other Exchanges ASKER:SwedenASKERs:UK
Address Svardvagen 3A, Danderyd, SWE, 182 33
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
23GF Score

Get the complete analysis for FRA:I88

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.29
Price